NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NINDS E-225-2009-0-PCT-02 Compositions And Methods For The Treatment Or Prevention Of Mitochondrial Diseases PCT PCT PCT/US10/054802 Expired
NCI E-132-2010-0-PCT-02 Methods Of Diagnosing And Prognosing Colonic Polyps PCT PCT PCT/AU10/001432 Expired
NCI E-199-2010-0-US-01 Fluoroquinolone Derivatives As Inhibitors Of Tyrosyl-DNAphosphodiesterase (Tdp1) US 61/407,325 Abandoned
NCI E-191-2002-0-US-09 CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF. US CON 12/909,979 8278348 Expired PDF
NEI E-198-2008-0-PCT-02 Systemic Immunosuppression In The Treatment Of Age Related Macular Degeneration and Diabetic Retinopathy PCT PCT PCT/US2010/053734 Abandoned
NCI E-236-2010-0-US-01 ANTI-MAGE-A3-T Cell Receptors And Related Materials And Methods of Use US 61/405,668 Abandoned
NIAID E-301-2009-0-PCT-02 RSV Immunogens, Antibodies And Compositions Thereof PCT PCT PCT/US2010/053558 Expired
NCI E-118-2011-0-US-01 Devices And Methods For Mapping Nucleic Acids In Tissue US 61/405,502 Abandoned
NIAID E-018-2010-0-IN-06 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites IN National Stage 4311/DELNP/2012 Issued
NIAID E-018-2010-0-CA-04 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites CA National Stage 2777744 Issued
NIAID E-018-2010-0-DK-12 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites DK EP 10771611.0 Issued
NIAID E-018-2010-0-EP-05 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites EP National Stage 10771611.0 Issued
NIAID E-018-2010-0-FR-13 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites FR EP 10771611.0 Issued
NIAID E-018-2010-0-DE-11 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites DE EP 10771611.0 Issued
NIAID E-018-2010-0-NL-15 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites NL EP 10771611.0 Issued
NIAID E-018-2010-0-GB-14 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites GB EP 10771611.0 Issued
NIAID E-018-2010-0-AU-03 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites AU National Stage 2010306559 Issued
NIAID E-018-2010-0-JP-07 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites JP National Stage 2012-534414 Issued
NIA E-051-2008-0-US-07 Compositions And Methods For Delivering Inhibitory Oligonucleotides US National Stage 12/988,148 8703921 Issued PDF
NIAID E-018-2010-0-ZA-09 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites ZA National Stage 2012/03551 Issued
NHGRI E-055-2005-2-US-04 Farnesyl Transferase Inhibitors (FTIs) For Treatment Of Laminopathies, Cellular Aging, And Artherosclerosis US DIV 12/905,838 8257915 Abandoned PDF
NIAID E-018-2010-0-PCT-02 Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccinia Virus Containing Restructures Insertion Sites PCT PCT PCT/US2010/052929 Expired
NIAID E-007-2010-1-PCT-01 Nucleic Acid Sequences Encoding Expandable HIV Mosaic Proteins PCT PCT COMB PCT/US2010/052916 Expired
NCI E-072-2001-0-US-05 Identification of New Small RNAs and ORFs Of E. Coli As Mediators Of Cell And Intercell Regulation US DIV 12/905,288 Abandoned
CC E-029-2011-0-US-01 FEEDBACK CONTROL FOR MILD HYPERTHERMIA TREATMENTS USING MAGNETIC RESONANCE GUIDED FOCUSED ULTRASOUND US 61/393,469 Abandoned
NCI E-270-2010-0-US-01 Mutations In Metastatic Prostate Cancer US 61/393,757 Abandoned
NINDS E-144-2008-0-US-04 Movement Correction In MRI Using A Camera US National Stage 12/937,852 9545217 Abandoned PDF
NINDS E-081-2008-2-US-05 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems US National Stage 12/937,843 9084820 Issued PDF
NIA E-051-2008-0-JP-06 Compositions and Methods for Delivering Inhibitory Oligonucleotides JP National Stage 2011-505154 Abandoned
NHLBI E-138-2008-0-US-03 Peptides Promoting Lipid Efflux US National Stage 12/937,974 8936787 Issued PDF
NIMH E-274-2015-0-PCT-02 COMPOSITIONS AND METHODS FOR TREATING BLADDER CANCER PCT PCT PCT/US2010/52634 Expired
NCI E-174-2008-0-JP-07 Therapeutic Targeting Of CSN5, A Negative Regulator Of P53 And P27, In Human Hepatocellular Carcinoma JP National Stage 2011-505173 Abandoned
NIAID E-197-2010-0-US-01 Compositions And Methods For Controlling Neurotropic Viral Pathogenesis By MicroRNA Targetting US 61/455,261 Abandoned
NCI E-174-2008-0-US-03 Silencing Of CSN5 Gene Expression Using Interfering RNA US National Stage 12/903,558 8227443 Issued PDF
NIAID E-010-2011-0-PCT-02 Recombinant MVA Viruses Expressing Clades A/G, B, And C Modified HIV env, Gag And Pol Genes; Recombinant MVA Expressing GM-CSF. PCT PCT PCT/US2010/52484 Expired
NCI E-077-2008-0-US-03 Methods and Compositions For the Delivery of Vaccines to Disrupted Epithelium US National Stage 12/863,572 Abandoned
NCATS E-211-2010-0-US-01 Compounds And Methods For The Treatment Of Giardiasis US 61/392,096 Abandoned
NCI E-158-2009-0-CA-04 Granulysin In Immunotherapy CA National Stage 2777400 Abandoned
NCI E-158-2009-0-EP-05 Granulysin In Immunotherapy EP National Stage 10823873.4 Abandoned
NCI E-158-2009-0-AU-03 Granulysin In Immunotherapy AU National Stage 2010307075 Abandoned
NIAID E-142-2008-0-US-03 Humanized Monoclonal Antibodies That Specifically Bind And/Or Neutralize Japanese Encephalitis Virus (JEV) And Their Use US National Stage 12/937,227 8506961 Abandoned PDF
NCI E-158-2009-0-PCT-02 Granulysin In Immunotherapy PCT PCT PCT/US2010/052036 Expired
NIDDK E-173-2008-0-US-03 MDCK Cells With Human Siat7e Gene Inserts Exhibit Capability Of Anchorage-independent Growth US National Stage 12/937,185 Abandoned
NCI E-232-2009-0-AU-03 Human Domain Antibodies Against Components Of The Human Insulin-like Growth Factor (IGF) System AU National Stage 2010303383 Abandoned
NCI E-232-2009-0-PCT-02 Human Domain Antibodies Against Components Of The Human Insulin-like Growth Factor (IGF)System PCT PCT PCT/US2010/051784 Expired
NCI E-232-2009-0-EP-05 Human Domain Antibodies Against Components Of The Human Insulin-like Growth Factor (IGF) System EP National Stage 10822676.2 Abandoned
NCI E-232-2009-0-CA-04 Human Domain Antibodies Against Components Of The Human Insulin-like Growth Factor (IGF) System CA National Stage 2774953 Abandoned
NIA E-081-2007-0-US-03 Cancer Chemoprevention Strategy Based On Loss Of Imprinting Of IGF2 US National Stage 12/446,735 Abandoned
NIAID E-006-2010-1-PCT-01 Mechanisms For Protection Against Pandemic Strains Of Influenza PCT PCT COMB PCT/US2010/051512 Expired
NIDCR E-009-2011-0-PCT-01 Treatment Of The Sjogren's Syndrome PCT PCT PCT/NL10/050650 Expired